News
COVID-19 and clinical trials : point of view of Rémi Quirion
In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Rémi Quirion, Chief Scientist of Quebec. Q. How do you think the COVID-19 pandemic will alter current and future clinical
COVID-19 and clinical trials : point of view of Alan Bernstein
COVID-19 and clinical trials : point of view of Alan Bernstein In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Alan Bernstein, President and CEO, CIFAR. Q. How do you
International Clinical Trials’ Day: Clinical Research Saves Lives
International Clinical Trials’ Day: Clinical Research Saves Lives For the International Clinical Trials’ Day, CATALIS asked the leaders in the field: “Why is clinical research essential?“ “Clinical research exposes physicians and their teams to cutting-edge technologies that help to challenge and improve current care.” “Clinical research is in the continuum of the innovation chain. Academic research laboratories are
COVID-19 and clinical trials : point of view of Dominique Johnson
COVID-19 and clinical trials : point of view of Dominique Johnson In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dominique Johnson, General Manager, McPeak-Sirois Group for Clinical Research in
COVID-19 and clinical trials : point of view of Julie Autmizguine
COVID-19 and clinical trials : point of view of Julie Autmizguine In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Julie Autmizguine, Assistant Director of Clinical Research, Sainte-Justine UHC
COVID-19 and clinical trials : point of view of Luc Feldmann
COVID-19 and clinical trials : point of view of Luc Feldmann In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Luc Feldmann, Director, International Centre of Therapeutic Research, Servier Canada.
COVID-19 and clinical trials : point of view of Angela Genge
In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Angela Genge, Neurologist and Director, Clinical Research Unit, Montreal Neurological Institute-Hospital.
COVID-19 and clinical trials : point of view of Dr. Gerald Batist
In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders
in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following
statements detail the point of view of Dr. Gerald Batist, Deputy Director and Senior Investigator, Jewish
General Hospital’s Lady Davis Institute.
COVID-19 and clinical trials : point of view of Vatche Bartekian
In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and look for ways to adapt. The following statements detail the point of view of Vatche Bartekian, President of Vantage BioTrials Inc.
COVID-19 and clinical trials : point of view of Marc Rivière
In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and look for ways to adapt. The following statements detail the point of view of Marc Rivière, Chief Medical Officer, TVM Capital and Chairman of the Board of Directors, CATALIS Québec.